Skip to content

Drug interactions

Atogepant + Temsirolimus

Severity: Minor

Atogepant and Temsirolimus: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Temsirolimus is a CYP3A4 substrate and not a clinically meaningful CYP3A4 inhibitor, so a substantive increase in atogepant exposure is unlikely. No clear clinical interaction can be described.

What this interaction means in plain words

Atogepant and Temsirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Predicted CYP3A4 effect is not established; temsirolimus is not a recognized CYP3A4 inhibitor.

What to do

No specific action is needed beyond routine monitoring of tolerability.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Temsirolimus?

MediHelp rates the interaction as minor. Atogepant and Temsirolimus have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Temsirolimus is a CYP3A4 substrate and not a clinically meaningful CYP3A4 inhibitor, so a substantive increase in atogepant exposure is unlikely. No clear clinical interaction can be described.

How serious is the interaction between Atogepant and Temsirolimus?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed beyond routine monitoring of tolerability.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in